newsfilter
← Latest News
GlobeNewswire·

Genenta Science Provides Update on CEO Ownership

MILAN and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ:GNTA), a clinical-stage gene-therapy company developing hematopoietic stem-cell-based immunotherapies for solid tumors, provides an update